Anebulo Pharmaceuticals CEO Simon Allen's 2023 pay falls 63% to $778K
Anebulo Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: October 30, 2023
Anebulo Pharmaceuticals reported fiscal year 2023 executive compensation information on October 30, 2023.
In 2023, four executives at Anebulo Pharmaceuticals received on average a compensation package of $455K, a 37% decrease compared to previous year.
Average pay of disclosed executives at Anebulo Pharmaceuticals
Simon Allen, Chief Executive Officer, received $778K in total, which decreased by 63% compared to 2022. 61% of Allen's compensation, or $473K, was in salary. Allen also received $164K in bonus and $141K in option awards.
Kenneth C. Cundy, Chief Scientific Officer, received a compensation package of $496K, which increased by 1% compared to previous year. 73% of the compensation package, or $362K, was in salary.
Rex Merchant, Chief Financial Officer, earned $299K in 2023, a 9% increase compared to previous year.
Sandra A. Gardiner, Chief Financial Officer, received $246K in 2023.
Anebulo Pharmaceuticals' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on October 30, 2023.